ITOS
Price
$10.17
Change
-$0.01 (-0.10%)
Updated
Jun 6 closing price
Capitalization
389.24M
61 days until earnings call
TIL
Price
$32.89
Change
+$2.56 (+8.44%)
Updated
Jun 6 closing price
Capitalization
215.76M
Interact to see
Advertisement

ITOS vs TIL

Header iconITOS vs TIL Comparison
Open Charts ITOS vs TILBanner chart's image
iTeos Therapeutics
Price$10.17
Change-$0.01 (-0.10%)
Volume$1.06M
Capitalization389.24M
Instil Bio
Price$32.89
Change+$2.56 (+8.44%)
Volume$336.86K
Capitalization215.76M
ITOS vs TIL Comparison Chart
Loading...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITOS vs. TIL commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a Buy and TIL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ITOS: $10.17 vs. TIL: $32.89)
Brand notoriety: ITOS and TIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 70% vs. TIL: 122%
Market capitalization -- ITOS: $389.24M vs. TIL: $215.76M
ITOS [@Biotechnology] is valued at $389.24M. TIL’s [@Biotechnology] market capitalization is $215.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileTIL’s FA Score has 1 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • TIL’s FA Score: 1 green, 4 red.
According to our system of comparison, both ITOS and TIL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 5 TA indicator(s) are bullish while TIL’s TA Score has 6 bullish TA indicator(s).

  • ITOS’s TA Score: 5 bullish, 4 bearish.
  • TIL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TIL is a better buy in the short-term than ITOS.

Price Growth

ITOS (@Biotechnology) experienced а +1.50% price change this week, while TIL (@Biotechnology) price change was +22.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ITOS is expected to report earnings on Aug 07, 2025.

TIL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITOS($389M) has a higher market cap than TIL($216M). TIL YTD gains are higher at: 72.289 vs. ITOS (32.422). TIL has higher annual earnings (EBITDA): -62.53M vs. ITOS (-146.71M). ITOS has more cash in the bank: 520M vs. TIL (113M). ITOS has less debt than TIL: ITOS (5.05M) vs TIL (86.9M). ITOS has higher revenues than TIL: ITOS (35M) vs TIL (0).
ITOSTILITOS / TIL
Capitalization389M216M180%
EBITDA-146.71M-62.53M235%
Gain YTD32.42272.28945%
P/E RatioN/AN/A-
Revenue35M0-
Total Cash520M113M460%
Total Debt5.05M86.9M6%
FUNDAMENTALS RATINGS
TIL: Fundamental Ratings
TIL
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSTIL
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACEVX10.26N/A
N/A
American Century International Val Inv
RYPIX56.68N/A
N/A
Rydex Transportation Inv
WSBFX22.09N/A
N/A
Boston Trust Walden Balanced
FSWCX12.04N/A
N/A
Fidelity SAI US Value Index
OFAVX25.73N/A
N/A
Olstein All Cap Value A

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-0.10%
BMRN - ITOS
49%
Loosely correlated
+2.50%
IMNM - ITOS
45%
Loosely correlated
+0.11%
IBO - ITOS
44%
Loosely correlated
-5.40%
BDTX - ITOS
43%
Loosely correlated
+3.61%
RCUS - ITOS
43%
Loosely correlated
+3.53%
More

TIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, TIL has been loosely correlated with BNTX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if TIL jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TIL
1D Price
Change %
TIL100%
+8.44%
BNTX - TIL
55%
Loosely correlated
-1.51%
SMMT - TIL
52%
Loosely correlated
+4.36%
XNCR - TIL
38%
Loosely correlated
+5.81%
DNLI - TIL
35%
Loosely correlated
+3.38%
ITOS - TIL
34%
Loosely correlated
-0.10%
More